Glycogen Synthase Kinase-3α Promotes Fatty Acid Uptake and Lipotoxic Cardiomyopathy-Reference-Cited by-同舟云学术

Glycogen Synthase Kinase-3α Promotes Fatty Acid Uptake and Lipotoxic Cardiomyopathy

Published:2019-05 Issue:5 Volume:29 Page:1119-1134.e12
ISSN:1550-4131
Container-title:Cell Metabolism
language:en
Short-container-title:Cell Metabolism

Author:

Nakamura Michinari,Liu Tong,Husain Seema,Zhai Peiyong,Warren Junco S.,Hsu Chiao-Po,Matsuda Takahisa,Phiel Christopher J.,Cox James E.,Tian Bin,Li Hong,Sadoshima Junichi

Funder

U.S. Public Health Service

Leducq Foundation Transatlantic Network of Excellence

American Heart Association

Scientist Development

DRC

NIH

Publisher

Elsevier BV

Subject

Cell Biology,Molecular Biology,Physiology

Reference39 articles.

1. Effects of combination lipid therapy in type 2 diabetes mellitus;Ginsberg;N. Engl. J. Med,2010

2. A simplified, Langendorff-free method for concomitant isolation of viable cardiac myocytes and nonmyocytes from the adult mouse heart;Ackers-Johnson;Circ. Res.,2016

3. Distinct molecular regulation of glycogen synthase kinase-3alpha isozyme controlled by its N-terminal region: functional role in calcium/calpain signaling;Azoulay-Alfaguter;J. Biol. Chem.,2011

4. An ERK/Cdk5 axis controls the diabetogenic actions of PPARgamma;Banks;Nature,2015

5. Rodent models of diabetic cardiomyopathy;Bugger;Dis. Models Mech.,2009

Cited by 82 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Natural compound screening predicts novel GSK-3 isoform-specific inhibitors;Biochimie;2024-10

2. Intermedin Alleviates Diabetic Cardiomyopathy by Up-Regulating CPT-1β through Activation of the Phosphatidyl Inositol 3 Kinase/Protein Kinase B Signaling Pathway;Pharmaceuticals;2024-09-12

3. Glycogen synthase kinase‐3β: A multifaceted player in ischemia‐reperfusion injury and its therapeutic prospects;Journal of Cellular Physiology;2024-07-04

4. Mitochondrial glycerol 3-phosphate dehydrogenase deficiency exacerbates lipotoxic cardiomyopathy;iScience;2024-06

5. Glycogen synthase kinase 3 activity enhances liver inflammation in MASH;JHEP Reports;2024-06